Follow @eaonc
  • Home
  • About Us
    • Organizational Overview
    • Executive Leadership
    • Governance
    • Membership
    • Scientific Planning and Review
    • Trial Monitoring
    • Operations
    • Biostatistics and Data Management
    • Collaborations
    • Active Clinical Trials
    • Participating Institutions
    • Scientific Achievements
    • Constitution
  • Scientific Programs
    • Cancer Control and Outcomes Program
    • Therapeutic Studies Program
    • Biomarker Sciences Program
  • Research Support
    • Research Support Committees
    • Mentoring Program
    • Training and Education
  • Research Cores
    • Central Biorepository and Pathology Facility
    • Imaging Core Laboratory
    • Leukemia Integrated Translational Science Center
    • Leukemia Tissue Bank
    • Thoracic Malignancies Integrated Translational Science Center
  • Resources
    • Group Meetings
    • Trial Educational Materials
    • NCI-MATCH / EAY131 for Researchers
    • Publications
    • ECOG Performance Status
    • ECOG-ACRIN Sample Tracking System
    • CIRB
    • Medidata Rave®
    • TRIAD™
    • SOAPP
    • PrECOG
    • Related Websites
    • Document Library
  • Patients
    • Myths and Facts
    • Resources
    • Trial Educational Materials
  • News and Info
    • Announcements
    • e-Newsletter
    • Press Releases
  • Contact Us
    • Donations
    • Locations
    • Office of Communications
    • Participating Institutions
    • Principal Investigators
Follow @eaonc

Trial Educational Materials

Educational Materials for Active Trials

Numerous clinical trials are always open and enrolling patients in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults 18 years of age and older who have or are at risk of developing cancer. This section of the website contains all educational materials that are publicly available to patients and researchers.

To access educational materials for a particular trial, click on the trial ID in the list below.

Cancer Type

Trial ID and Target Patient Population

Any Solid Tumor, Lymphoma, or Myeloma, or Cancer Type with No Standard Treatment Available NCI-MATCH / EAY131 – Eligibility Based on Genetic Testing
Brain EAF151 – Recurrent Glioblastoma
Breast EA1131 – Triple-Negative (Including Men)
EA1151 aka TMIST – Breast Cancer Screening
EAI142 – Newly Diagnosed, Advanced
6694 – Imaging of Women in the Alliance A011104 Trial
A011401 aka BWEL – Role of Weight Loss in Overweight Women with Early Breast Cancer
Cancer Care Delivery Research EAQ161CD – Assessment of Biomarker Testing Practices
EAQ162CD – Assessment of Financial Burden, Colon/Rectal
Cancer Control EA9131 – Acute Promyelocytic Leukemia (APL)
and Survivorship EAQ152 aka COMET – Education About Genomic Testing
E1Q11 aka EROS – Reproductive Health Planning
Gastrointestinal EA2142 – Pancreas or Gastrointestinal Tract, Advanced
EA2161 – Pancreas
EA2165 – Anal
EA2174 – Logoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
7151 – Detection of Colon Cancer (By Invitation Only)
Genitourinary EA8134 aka InPACT – Penis
EA8143 aka PROSPER RCC – Kidney
EA8153 aka CHAARTED2 – Hormone-sensitive Prostate
EA8171 – Newly-Diagnosed Prostate (Imaging)
Gynecologic EAE161 – Ovarian, Fallopian Tube, or Peritoneum
Head and Neck EA3132 – p53 Mutated  Squamous Cell, Removed by Surgery
EA3163 – Nasal and Paranasal Sinus Squamous Cell Carcinoma
Leukemia EA9152 – T-cell or B-cell Acute Lymphoblastic Leukemia (ALL)
EA9161 – Chronic Lymphocytic Leukemia (CLL) in Patients Aged 18-70 Years
EA9171 – Myeloid Leukemia
E1910 – Acute Lymphoblastic (ALL)
NHLBI-MDS aka The National MDS Study – Observation of Myelodysplastic Syndromes (MDS)
Lymphoma EA4151 – Mantle Cell
E4412 – Hodgkin
Melanoma EA6134 – Advanced, BRAFV600 Mutated
EA6141 – Advanced
EA6174 – Resected Merkel Cell Carcinoma
Myeloma EAA172 – Relapsed/Refractory
Thoracic EA5142, an ALCHEMIST treatment trial – Non-Small Cell Lung, Removed by Surgery and Treated with Chemotherapy
EA5152 – Previously Treated Non-Squamous NSCLC
EA5162 – Advanced NSCLC with Exon 20 Insertion Mutations in EGFR
E4512, an ALCHEMIST treatment trial – Early, Non-Squamous, Non-Small Cell Lung, Removed by Surgery
4703 aka DECAMP-1 – Detection of Early Lung Cancer in Military Personnel
4704 aka DECAMP-2 – Screening of Military Personnel with Early Stage Lung Cancer or at High Risk of Developing Lung Cancer
6697 – Imaging Substudy for Patients in the RTOG 1106 Trial
2091
Resources
Group Meetings
Trial Educational Materials
  • Closed or Completed Studies
NCI-MATCH / EAY131 for Researchers
Publications
ECOG Performance Status
CIRB
Medidata Rave®
TRIAD™
SOAPP
PrECOG
Related Websites
Document Library

© 2019 ECOG-ACRIN Cancer Research Group. All rights reserved.  |  Disclaimer